MedPath

PUNEET MITTAL

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients

Phase 2
Completed
Conditions
Treatment of Covid-19 Virus Infection
First Posted Date
2020-07-31
Last Posted Date
2020-12-22
Lead Sponsor
PUNEET MITTAL
Target Recruit Count
100
Registration Number
NCT04494204
Locations
🇮🇳

Govt Medical College and Govt General Hospital (Old RIMSGGH), Srikakulam, Andhra Pradesh, India

🇮🇳

Parul Institute of Ayurveda and Research Parul University, Vadodara, Gujrat, India

🇮🇳

Lokmanya Hospital, Pune, Maharashtra, India

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.